Dissolvable microneedles deliver doxorubicin to basal cell lesions, showing promising phase 2 clearance and opening hope for Gorlin syndrome patients.
Raza Bokhari, MD
Advertisement
Raza Bokhari, MD, is the executive chairman and chief executive officer of Medicus Pharma.
Articles by Raza Bokhari, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: Skin Cycling
2
Clinique's Daily Calm Merges Clinical Efficacy with Color Cosmetics for Sensitive Skin
3
What Dermatologists Need to Know About the First New Sunscreen Ingredient in Decades
4
First HA Injectable for Neck Wrinkles Cleared by FDA
5